Zydus Cadila, Alembic Pharma arms review drugs in US

Overview

• Post By :


• Source: PTI


• Date: 31 Mar,2021

New Delhi, Mar 30 (PTI) US-based arms of national pharma companies Zydus Cadila and Alembic Pharmaceuticals are recalling one drug each in the US after receiving complaints against the products.
Administration of crystallized Acyclovir Sodium Injection, 50 mg/mL has a possibility of life threatening adverse consequences, it added.

“To date, Zydus Pharmaceuticals (USA) Inc has not received any reports of adverse events related to this product recall,” the company said.

The business has notified its distributors and customers by email and FedEx overnight courier service and is arranging for the return of recalled Acyclovir Sodium Injection, 50 mg/mL lots.

Hospitals which have the product that has been recalled should stop using it immediately and telephone the company”s recall coordinating center, it added.

Another firm Alembic Pharmaceuticals Inc is voluntarily recalling one lot of Telmisartan tablets, USP, 20 mg, packed with 30-count bottles to the consumer level, the company said in an announcement on the United States Food and Drug Administration”s (USFDA) website.

The product has been recalled due to a market complaint received which said that one bottle labelled as 30-count Telmisartan tablets, USP, 20 mg wrongly contained 30 pills of Telmisartan, USP, 40mg, it added.

Patients who might be on a double dose of Telmisartan for a prolonged time period, could experience low blood pressure, worsening of kidney function, or an elevation of potassium that may be life-threatening, the company said.

“To date, Alembic Pharmaceuticals Ltd has not received any reports of adverse events associated with the recall,” it added.

Alembic Pharmaceuticals Ltd is notifying its distributors and retailers through a letter and is arranging for the return of the recalled lot, the company said. PTI AKT ANU ANU